Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
541,749.22 Euro
Request Reference:
ULS São José 51039924 - URGENTE
Request Name:
Bleomicina 15000 U.I. pó sol inj fr IA Intralesional IM Iperitoneal IpleuraL IV, Etanercept 25 mg pó sol inj fr SC, Lenvatinib 10 mg cáps, Sunitinib 25 mg cáps e Tildracizumab 100 mg/1 ml sol inj ser
Phase:
Tendering Phase
State:
Awarded
Description:
Aquisição de Bleomicina 15000 U.I. pó sol inj fr IA Intralesional IM Iperitoneal IpleuraL IV, Etanercept 25 mg pó sol inj fr SC, Lenvatinib 10 mg cáps, Sunitinib 25 mg cáps e Tildracizumab 100 mg/1 ml sol inj ser 1 ml SC
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
B369 - BLEOMICINA (PÓ P/ SOL INJ) [15.000 U.I.; FRS]
-
146
(
Days
)
E199 - ETANERCEPT [25 MG/ML; 1 ML; FRS]
-
146
(
Days
)
L1066 - LENVATINIB [10 MG; CÁP/ COMP]
-
146
(
Days
)
S349 - SUNITINIB [25 MG; CÁP/COMP]
-
146
(
Days
)
T1636 - TILDRACIZUMAB [100 MG/ 1 ML; SOL INJ; SERINGA]
-
146
(
Days
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Rua José António Serrano 1150-199 Arroios Lisboa PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
8/7/2024 8:47 AM
(UTC +1 hour)
National official publishing date and time (DR):
9/4/2023 8:36 AM
(UTC +1 hour)
Due datetime for receiving replies:
8/9/2024 2:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
convite 41039924.pdf
convite 41039924.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Lot Title
B369 - BLEOMICINA (PÓ P/ SOL INJ) [15.000 U.I.; FRS]
Base Price
5 040,00
1.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
B369
BLEOMICINA (PÓ P/ SOL INJ) [15.000 U.I.; FRS]
250,000000
NXTWY.UMT.17649
Buyer Comment:
508622263 | Accord Healthcare, Unipessoal, Lda. | CPA:2023491/528/0543 | NºAIM:5689260;
TOTAL
(The amounts shown do not include VAT)
2
Lot Title
E199 - ETANERCEPT [25 MG/ML; 1 ML; FRS]
Base Price
4 632,18
2.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
E199
ETANERCEPT [25 MG/ML; 1 ML; FRS]
84,000000
NXTWY.UMT.17649
Buyer Comment:
500162166 | Laboratórios Pfizer, Lda. | CPA:2023491/96/0511 | NºAIM:4163788;
TOTAL
(The amounts shown do not include VAT)
3
Lot Title
L1066 - LENVATINIB [10 MG; CÁP/ COMP]
Base Price
16 500,00
3.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
L1066
LENVATINIB [10 MG; CÁP/ COMP]
300,000000
NXTWY.UMT.17649
Buyer Comment:
507847660 | EF - Eisai Farmacêutica, Unipessoal, Lda. | CPA:2023491/493/0418 | NºAIM:5654769;
TOTAL
(The amounts shown do not include VAT)
4
Lot Title
S349 - SUNITINIB [25 MG; CÁP/COMP]
Base Price
40 577,04
4.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
S349
SUNITINIB [25 MG; CÁP/COMP]
672,000000
NXTWY.UMT.17649
Buyer Comment:
500162166 | Laboratórios Pfizer, Lda. | CPA:2023491/96/0523 | NºAIM:5072079; 501505334 | Farmoz - Soc. Técnico Medicinal, S.A. | CPA:2023491/46/0671 | NºAIM:5840301; 502248793 | Mylan, Lda. | CPA:2023491/120/0697 | NºAIM:5770136; 508622263 | Accord Healthcare, Unipessoal, Lda. | CPA:2023491/528/0608 | NºAIM:5818521;
TOTAL
(The amounts shown do not include VAT)
5
Lot Title
T1636 - TILDRACIZUMAB [100 MG/ 1 ML; SOL INJ; SERINGA]
Base Price
475 000,00
5.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
T1636
TILDRACIZUMAB [100 MG/ 1 ML; SOL INJ; SERINGA]
250,000000
NXTWY.UMT.17649
Buyer Comment:
503538108 | Logista, Transportes, Transitários e Pharma, Unipessoal, Lda. | CPA:2023491/1001/0019 | NºAIM:5758677;
TOTAL
(The amounts shown do not include VAT)
Evaluation
Evaluation
Vision
Avaliação
Definir modelo de avaliação
Sim
Não
Modalidade de avaliação
Selecione…
Monofator
Método de Avaliação
Selecione…
Manual
Divulgar critérios de avaliação
Sim
Não
Critérios da Avaliação
1 - B369 - BLEOMICINA (PÓ P/ SOL INJ) [15.000 U.I.; FRS]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
2 - E199 - ETANERCEPT [25 MG/ML; 1 ML; FRS]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
3 - L1066 - LENVATINIB [10 MG; CÁP/ COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
4 - S349 - SUNITINIB [25 MG; CÁP/COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
5 - T1636 - TILDRACIZUMAB [100 MG/ 1 ML; SOL INJ; SERINGA]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...